Humana reported second-quarter earnings that surpassed Wall Street expectations, driven by strong performance in its insurance and CenterWell healthcare services units. The company posted adjusted earnings per share of $7.61, above the $7.22 anticipated, and revenue of $40.87 billion, modestly beating estimates. Net income rose to $694 million compared to $545 million a year earlier, reflecting gains from both new and existing members. Despite solid results, Humana’s shares dropped over 6% following the report.

A key factor in the results was the company’s management of medical costs, which aligned closely with its projections. Humana’s medical benefit ratio came in at 91.2%, consistent with expectations but slightly higher than the 89.9% recorded in the previous year. CFO Celeste Mellet highlighted stable medical cost trends and noted slight improvements in inpatient care costs among members treated by value-based providers. Pharmacy expenses remain elevated, influenced by rising drug prices and new medications, though Humana expects a modest increase in these costs next year.

Humana continues to navigate challenges affecting the Medicare Advantage sector, such as increased demand for care delayed during the pandemic and high-cost specialty drugs. While some competitors have raised profit forecasts, Humana maintained its adjusted earnings outlook for 2026 at a minimum of $9 per share. Analysts viewed the steady guidance as somewhat disappointing given the broader industry trend of upgraded forecasts, though the company remains focused on controlling costs and improving health outcomes.

Looking ahead, Humana plans to implement adjustments to its 2027 Medicare Advantage offerings aimed at boosting profitability and targeting a pretax margin of at least 3% by 2028. The insurer remains optimistic about growth through expanding membership, enhancing plan quality ratings, maintaining pricing discipline, and managing expenses. Overall, Humana’s latest report reflects cautious confidence amid ongoing sector pressures and evolving healthcare dynamics.